Summit Therapeutics Inc (NAS:SMMT)
$ 17.51 +0.23 (+1.33%) Market Cap: 13.97 Bil Enterprise Value: 13.30 Bil PE Ratio: 0 PB Ratio: 22.16 GF Score: 30/100

Summit Therapeutics Inc (SMMT) Transcripts

  • 1